Trial intelligence / Profile preview

Tranexamic acid for prevention of increased hemorrhage in traumatic brain injury

IRCT201011202854N6Phase 3Completed

Sponsor
Kashan University of Medical Sciences
Start
Apr 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of tranexamic acid in traumatic brain injury (TBI) and intracerebral hemorrhage (ICH), sponsored by Kashan University of Medical Sciences. Started Apr 2013; status: completed.

02

Drugs

tranexamic acid
03

Conditions

traumatic brain injury (TBI)intracerebral hemorrhage (ICH)

Beyond the preview

Go deeper on IRCT201011202854N6.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201011202854N6.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call